The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular
conditions. These Roadmaps identify potential roadblocks and their solutions to improve the …

The global burden of rheumatic heart disease continues to be significant although it is
largely limited to poor and marginalized populations. In most endemic regions, affected …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

Background: Chagas Disease is a neglected tropical disease caused by the protozoan
Trypanosoma cruzi, with some of the most serious manifestations affecting the …

More than 500 million people worldwide live with cardiovascular disease (CVD). Health
systems today face fundamental challenges in delivering optimal care due to ageing …

The ideal pathway of care for heart failure patients is a key feature of this consensus
document. It offers a pathway of care that is the foundation from which to assess barriers that …

Summary Background The World Health Assembly 2018 approved a resolution on
rheumatic heart disease to strengthen programmes in countries where this condition …

Background Rheumatic heart disease (RHD) is a devastating yet preventable condition that
disproportionately affects low‐middle–income countries and indigenous populations in …

Abstract Background The World Heart Federation has undertaken an initiative to develop a
series of Roadmaps. Objectives The aim of these is to promote development of national …

Infections with Streptococcus pyogenes and their sequelae are responsible for an estimated
18 million cases of serious disease with> 700 million new primary cases and 500,000 …